eGenesis, Inc.

Associate Director, Regulatory Affairs

eGenesis, Inc.  •  $162k/yr  •  Cambridge, MA (Onsite)  •  12 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.
43
AI Success™

Job Description

About eGenesiseGenesis is a clinical-stage biotechnology company developing human-compatible engineered organs to address the severe global organ shortage. The Company’s proprietary genome engineering platform enables extensive, multiplex gene edits to remove key biological barriers, add protective human transgenes, and inactivate endogenous retroviruses. EGEN-2784, a genetically engineered porcine kidney, is the Company’s lead program and is currently being evaluated in a multi-patient Expanded Access study at MGH. eGenesis is headquartered in Cambridge, MA. 
Reporting to the Senior Vice President of Development and based in our Cambridge, MA office, the Associate Director of Regulatory Affairs is responsible for developing and executing regulatory strategies to ensure that all regulatory requirements and goals are met, from regulatory pathway planning to submission, in accordance with industry standards. The field of xenotransplantation is relatively uncharted and involves a complex relationship between the FDA Center for Veterinary Medicine (CVM) for the transgenic donor animals and Center for Biologics Evaluation and Research (CBER) for the organ product and transplantation to humans.

PRIMARY RESPONSIBILITIES

  • Collaborate cross-functionally to create regulatory strategies for each transplant organ program and successfully manage complex issues which have significant impact on the business
  • Lead definition of regulatory milestones and ensure that the company remains on track to support achievement of those milestones
  • Lead and manage consultants and CROs who are charged to support regulatory activities
  • Manage all activities pertaining to interactions and communications with FDA and other regulatory agencies in the United States, and other global agencies as needed
  • Provide regulatory oversight in the preparation and review of draft and final submissions/reports
  • Work cross-functionally to anticipate the impact of current and emerging trends, identify potential opportunities and threats, and advise departments and project teams accordingly
  • Participate in and sometimes lead interactions with FDA and other regulatory authorities for assigned projects to ensure acceptance, review, and approval of INDs, INADs, NADAs, BLAs, amendments
  • Host FDA/third party regulatory audits and ensure follow up on findings/observations
  • Represent eGenesis at company and industry committees, conferences, and organizations
  • Ability to work independently while fostering collaboration of team members in other functions

BASIC QUALIFICATIONS

  • Bachelor’s degree with 7+ years of experience in Regulatory Affairs (advanced degree preferred)
  • Experience in the successful development and registration of therapeutics, including:
  • Requirements for clinical protocol development, study/trial conduct, data collection, and data analysis
  • Knowledge of manufacturing requirements
  • Understanding of quality assurance and GxP requirements
  • Preparation of meeting requests and submissions (e.g., VIP, INTERACT, pre-IND, IND, NADA, BLA)
  • Negotiation with and presenting to regulatory agencies
  • Hands-on, roll-up-your-sleeves approach with the ability to simultaneously handle multiple project issues while dealing with time demands, incomplete information, or unexpected events

  • Base pay range is $161,600 - $242,400
eGenesis, Inc.

About eGenesis, Inc.

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation.

eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant.

Industry
Biotech & Life Sciences
Company Size
51-200 employees
Headquarters
Cambridge, MA
Year Founded
2015
Social Media